🧬 biology

Production of L-asparaginase by Pseudomonas reptilivora ATCC 13626 (NRRL B-6bs): First fractional factorial screening and discovery of ureolytic activity

This study reports the first systematic screening of L-asparaginase production by *Pseudomonas reptilivora* ATCC 13626, identifying low agitation and asparagine supplementation as key factors for high enzyme yield while simultaneously discovering an inducible ureolytic capacity that challenges the species' classical classification.

Original authors: Carlos Tinoco-Gutierrez, Hugo Israel Olvera-Calderón, Itan Homero Ruiz-Hernandez, Juan Carlos González-Hernández

Published 2026-08-04

📖 5 min read🧠 Deep dive

CC BY 4.0

Original authors: Carlos Tinoco-Gutierrez, Hugo Israel Olvera-Calderón, Itan Homero Ruiz-Hernandez, Juan Carlos González-Hernández

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

Imagine a tiny, invisible factory inside your body that is under attack by a very tricky enemy: a type of blood cancer called acute lymphoblastic leukemia. To fight this, doctors use a special tool called an enzyme, a biological machine named L-asparaginase. Think of this enzyme as a hungry Pac-Man that eats a specific nutrient called asparagine. The cancer cells are like greedy kids who forgot how to make their own snacks; if you take away their asparagine, they starve and die, while healthy cells, which can make their own snacks, keep going.

Right now, the "Pac-Man" tools doctors use are made by bacteria like E. coli. But these tools have a few problems: they get eaten by the body's immune system too quickly (like a cookie crumbling in your hand), and sometimes the body gets allergic to them. Scientists are always on the hunt for new, better factories that can make this enzyme without causing trouble. They are looking for bacteria that are tough, efficient, and maybe even a bit surprising. This is where the story of a specific microbe called Pseudomonas reptilivora comes in. It's a bacterium that scientists have known for a long time, but they thought it was a bit boring when it came to making this specific enzyme. They also thought it couldn't eat a common nitrogen source called urea. But what if they were wrong?

The Great Microbe Makeover

In this study, a team of researchers decided to give Pseudomonas reptilivora a makeover. They wanted to see if they could wake up this bacterium and get it to produce a lot of the cancer-fighting L-asparaginase. They set up a series of experiments in small glass flasks, kind of like a cooking show where they are testing different recipes to see which one makes the best cake.

The scientists played with three main ingredients to see how they affected the bacteria's performance:

Agitation: How fast they shook the flasks (like stirring a pot). They tested a slow stir (150 rpm) and a fast stir (230 rpm).
Urea: A nitrogen source they thought might help, or maybe hurt.
Asparagine: The specific nutrient the enzyme eats, which they hoped would act as a signal to turn the enzyme production on.

The Big Surprise: Urea is a No-Go

The first major discovery was a total plot twist. For decades, textbooks said this specific bacterium was "urease-negative," meaning it couldn't break down urea. It was like saying a dog can't bark. But when the researchers put the bacteria in a special dish with only urea to eat, the bacteria didn't just survive; they thrived and turned the dish pink, proving they were breaking down the urea. They even found that the bacteria could grow in a soup with no other food sources, proving they had a secret superpower to eat urea. This was the first time anyone had seen Pseudomonas reptilivora do this. It turns out the bacteria had been hiding this ability, waiting for the right conditions to show it off.

The Recipe for Success

When it came to making the L-asparaginase enzyme, the researchers found that the "recipe" mattered a lot. They discovered that the bacteria were very sensitive to how hard they were shaken.

The Shaking Speed: When they shook the flasks too fast (230 rpm), the bacteria got stressed, and the enzyme production dropped. It's like trying to build a sandcastle while someone is kicking sand at you; the structure falls apart. But when they slowed the shaking down to 150 rpm, the bacteria were happy and calm, and the enzyme production soared.
The Ingredients: Adding more asparagine (up to 5 grams per liter) acted like a green light, telling the bacteria to start churning out the enzyme. However, adding urea acted like a red light. Even though the bacteria could eat urea, having it in the mix actually stopped them from making the enzyme they needed. It's as if the bacteria got too full of urea snacks to bother making the special medicine.

The Winning Score

By combining the slow shaking (150 rpm) with a high dose of asparagine and zero urea, the team hit the jackpot. They managed to get the bacteria to produce 113.76 ± 7.60 U/mL of the enzyme. This is a huge jump compared to what was known before for this specific strain (which was only about 70 U/mL). They also found that the enzyme was very efficient, with a specific activity of 0.30 ± 0.02 U/mg protein·min.

What's Next?

The researchers are pretty sure they found a great starting point, but they also know they aren't at the finish line yet. The data showed a "curved" pattern, meaning the perfect recipe isn't just a simple straight line between the ingredients they tested; the best spot is likely somewhere in the middle of a more complex map. They suggest that future experiments should use a more advanced mapping technique (called Response Surface Methodology) to find the absolute perfect mix of speed and ingredients.

So, the story ends with a happy discovery: a bacterium that was thought to be boring and unable to eat urea is actually a hidden gem. With the right gentle shaking and the right snacks, it can become a powerful factory for making medicine to fight leukemia. It's a reminder that even in the microscopic world, there are always new secrets waiting to be stirred up.

Technical Summary: Production of L-asparaginase by Pseudomonas reptilivora ATCC 13626

Problem Statement
L-asparaginase (EC 3.5.1.1) is a critical therapeutic enzyme for treating acute lymphoblastic leukemia (ALL) and Hodgkin's lymphoma by depleting extracellular asparagine, thereby inducing metabolic starvation in leukemic cells. However, current commercial formulations derived from Escherichia coli and Erwinia chrysanthemi are limited by high immunogenicity rates (30–70%) and short half-lives. While various microbial hosts have been explored, yields vary significantly, and there is a need for alternative sources with improved bioprocess characteristics. Pseudomonas reptilivora ATCC 13626 (NRRL B-6bs) has historically been noted for basal L-asparaginase activity but remains under-explored as a production host. Furthermore, this strain has been classically classified as urease-negative, a status that may not reflect its full metabolic plasticity.

Methodology
The study employed a systematic fractional factorial screening approach to optimize L-asparaginase production in P. reptilivora ATCC 13626 using submerged fermentation in shake flasks.

Experimental Design: A $2^{3-1}$ fractional factorial design (Resolution III) was utilized to evaluate three operational factors: agitation speed (150–230 rpm), urea concentration (0–10 g/L), and L-asparagine concentration (1–5 g/L). The design included four factorial runs and two center points, with experiments performed in biological triplicates.
Culture Conditions: Fermentations were conducted in Tryptic Soy Broth (TSB) supplemented with specific nitrogen sources. Cultures were incubated at 28–30 °C for 48 hours.
Analytical Methods:
- Enzyme Activity: L-asparaginase activity was quantified via a modified aspartic acid hydroxyaminolysis method, requiring cell disruption to access the periplasmic enzyme fraction.
- Urease Activity: Ureolytic capacity was assessed through three independent methods: qualitative color change on modified Christensen's urea agar (peptone-free), growth in peptone-free media with urea as the sole nitrogen source, and quantitative urea depletion tracking using a urease-coupled Berthelot assay.
- Kinetics: Biomass (OD $_{600}$ and dry cell weight), glucose consumption, and urea concentration were monitored over time. Kinetic parameters (specific growth rate, doubling time, specific production rate) were calculated during the exponential phase.
Statistical Analysis: Data were analyzed using Minitab® 18, employing factorial regression, Pareto charts, and ANOVA to determine significant factors and curvature.

Key Results

L-asparaginase Production: The maximum volumetric activity of 113.76 ± 7.60 U/mL and specific activity of 0.30 ± 0.02 U/mg protein·min were achieved at 48 hours under low agitation (150 rpm) with 5 g/L L-asparagine and no urea (Treatment T4).
Factorial Effects:
- Agitation: This was the dominant significant factor. Low agitation (150 rpm) significantly enhanced specific activity and specific production rate ( $q_P$ ), whereas high agitation (230 rpm) suppressed these metrics, likely due to hydrodynamic shear stress damaging cell membranes.
- Substrates: L-asparagine acted as a strong inducer, while urea functioned as a repressor. The presence of urea generally reduced specific activity, suggesting nitrogen metabolite repression (NMR).
- Statistical Significance: While the linear model for volumetric activity lacked statistical significance due to limited degrees of freedom, specific activity and $q_P$ showed strong significance for agitation ( $p=0.015$ and $p=0.012$ , respectively).
Kinetics and Growth: All treatments exhibited diauxic growth, with D-glucose depletion occurring within the first 24 hours, followed by the utilization of secondary nitrogen sources. L-asparaginase synthesis was observed to accelerate after glucose exhaustion.
Ureolytic Discovery: Contrary to its historical classification, P. reptilivora ATCC 13626 demonstrated an inducible ureolytic capacity. Evidence included a distinct pH shift (yellow to pink) on urea agar, sustained growth in peptone-free media with urea as the sole nitrogen source, and quantitative urea consumption. This suggests the strain possesses a functional urease system, though molecular confirmation via ureABC sequencing is pending.
Nonlinearity: Significant curvature was detected across all response variables ( $p \leq 0.037$ ), indicating that the system exhibits nonlinear behavior and that the global optimum lies outside the current experimental domain.

Significance and Claims
The paper claims that P. reptilivora ATCC 13626 is a highly productive source of L-asparaginase, achieving a 62% increase over historical basal production levels (70 U/mL) without extensive optimization. The study identifies low agitation and the absence of urea as critical process levers for maximizing enzyme titers.

Crucially, the work reports the first discovery of ureolytic activity in this species, challenging its long-standing classification as urease-negative. This finding expands the known metabolic repertoire of P. reptilivora and suggests a potential nitrogen-scavenging mechanism that may influence enzyme production under stress.

The authors conclude that while the current screening provides a strong foundation, the observed nonlinear behavior necessitates a follow-up study using Response Surface Methodology (RSM), specifically a Box–Behnken design, to fully optimize the bioprocess for industrial scale-up. The paper positions P. reptilivora as a promising candidate for therapeutic enzyme production, pending further biochemical characterization and molecular validation of the urease system.

More like this